Adjusted EBITDA
Search documents
First Industrial Realty Trust(FR) - 2025 Q2 - Earnings Call Presentation
2025-07-17 15:00
Financial Performance - For the three months ended June 30, 2025, lease revenue was $177468 thousand, compared to $162075 thousand for the same period in 2024[14] - Net income available to common stockholders for the three months ended June 30, 2025, was $55185 thousand, compared to $51318 thousand for the same period in 2024[14] - Funds From Operations (FFO) allocable to common stockholders and unitholders for the three months ended June 30, 2025, was $102800 thousand, compared to $89647 thousand for the same period in 2024[15] - Adjusted Funds From Operations (AFFO) for the three months ended June 30, 2025, was $84160 thousand, compared to $74139 thousand for the same period in 2024[15] Portfolio Composition - As of June 30, 2025, the total number of in-service properties was 414, with a gross leasable area of 68044707 square feet and an occupancy rate of 942%[33] - Same Store NOI Cash Basis (Less Termination Fees) increased by 87% for the three months ended June 30, 2025, compared to the same period in 2024, reaching $121947 thousand[34] Debt Analysis - The total weighted average interest rate on debt outstanding was 410% as of June 30, 2025, compared to 416% as of June 30, 2024[21] - Fixed-rate debt accounted for $2379774 thousand of the total debt outstanding as of June 30, 2025[21] Leasing Activity - For the three months ended June 30, 2025, new leases commenced totaled 411 thousand square feet with a cash basis rent growth of 405%[36] - Tenant retention by square feet was 710% for the three months ended June 30, 2025[36] Outlook - The company estimates Funds From Operations - FFO (NAREIT) to be between $288 and $296 per share/unit for 2025[68]
Martin Midstream Partners(MMLP) - 2025 Q2 - Earnings Call Presentation
2025-07-17 13:00
Q2 2025 Performance - Adjusted EBITDA for Q2 2025 was $27.1 million[3], compared to $31.7 million in Q2 2024[3, 4], a decrease of 14.5% - The Transportation segment's Adjusted EBITDA decreased from $11.2 million in Q2 2024 to $8.5 million in Q2 2025[3, 4], a decrease of 24.1% - The Specialty Products segment's Adjusted EBITDA decreased from $5.7 million in Q2 2024 to $4.4 million in Q2 2025[3, 4], a decrease of 22.8% - The Sulfur Services segment's Adjusted EBITDA decreased from $10.6 million in Q2 2024 to $9.7 million in Q2 2025[3, 4], a decrease of 8.5% - The Terminalling & Storage segment's Adjusted EBITDA increased from $8.0 million in Q2 2024 to $8.4 million in Q2 2025[3, 4], an increase of 5% Full-Year 2025 Guidance - The company projects a full-year 2025 Adjusted EBITDA of $109.1 million[5] - Total segment adjusted EBITDA is projected to be $123.8 million[5] - Maintenance capital expenditures are estimated at $20.5 million, and plant turnaround costs at $5.4 million[5] - Total distributable cash flow is projected to be $27.8 million[5] - Total adjusted free cash flow is projected to be $18.8 million[5]
First Industrial Realty Trust Reports Second Quarter 2025 Results
Prnewswire· 2025-07-16 20:38
Core Insights - First Industrial Realty Trust, Inc. reported a diluted net income per share of $0.42 for Q2 2025, up from $0.39 in the same period last year, and funds from operations (FFO) of $0.76 per share/unit, compared to $0.66 a year ago [1][5][20] Portfolio Performance - The company's diverse portfolio is performing strongly, with cash rental rate growth among sector leaders and healthy renewal activity [2] - Cash basis same store net operating income (SS NOI) increased by 8.7%, driven by rental rate increases on new and renewal leases [6][26] - In-service occupancy was 94.2% at the end of Q2 2025, down from 95.3% at the end of Q1 2025 and Q2 2024 [6] Development and Leasing Highlights - During Q2 2025, the company leased 58,000 square feet at First Loop Logistics Park Building 4 in Orlando [3] - The company started two development projects totaling 402,000 square feet with an estimated total investment of $54 million [7] Investment and Capital Markets Highlights - The company completed its first public bond offering since 2007, issuing $450 million of 5.25% senior unsecured notes due January 15, 2031 [5][7] - The company received a 'BBB+' unsecured credit rating from Fitch Ratings [5][7] Financial Guidance - The company provided guidance for 2025, estimating net income available to common stockholders and unitholders between $1.53 and $1.61 per share/unit, and NAREIT FFO between $2.88 and $2.96 per share/unit [8][9]
Prologis Reports Second Quarter 2025 Results
Prnewswire· 2025-07-16 12:00
Core Insights - Prologis demonstrated resilient performance in a volatile environment, with strong operational execution and a high leasing pipeline [1][2] - The company reported a decrease in net earnings per diluted share by 33.7% to $0.61, attributed to lower gains and unrealized foreign exchange impacts, while Core FFO per diluted share increased by 9.0% to $1.46 [5][11] - Prologis has revised its 2025 guidance for net earnings and Core FFO, reflecting confidence in business strength despite the decrease in net earnings [4][33] Operating Performance - Average occupancy for Prologis was 94.9% with a period-end occupancy of 95.1% [2] - The company commenced leases totaling 51.2 million square feet, with a retention rate of 74.9% [2] - Cash Same Store NOI increased by 4.9%, while net effective rent change was reported at 53.4% [2] Deployment Activity - Prologis made acquisitions totaling $335 million and development starts of $846 million, with estimated weighted average yields of 6.3% and 6.9% respectively [2] - Estimated value creation from development stabilizations was $64 million, while total dispositions and contributions amounted to $96 million [2] Balance Sheet Strength & Liquidity - The company issued $5.8 billion in debt at a weighted average interest rate of 4.5% and a term of 5.4 years [3] - Total available liquidity was approximately $7.1 billion, with a debt-to-EBITDA ratio of 5.1x [6] Financial Guidance - Revised guidance for net earnings per diluted share is set between $3.00 and $3.15, while Core FFO is expected to be between $5.75 and $5.80 [4][33] - Average occupancy guidance was adjusted to 94.75% to 95.25%, with Cash Same Store NOI guidance revised to 4.25% to 4.75% [4] Revenue and Earnings - Total revenues for the quarter reached $2.184 billion, up from $2.008 billion in the previous year [11] - Net earnings attributable to common stockholders decreased to $570 million from $860 million year-over-year [11][14]
Algoma Steel Announces Conference Call and Provides Guidance for the Second Quarter 2025
Globenewswire· 2025-07-15 21:30
Core Viewpoint - Algoma Steel Group Inc. is set to release its Q2 2025 financial results on July 29, 2025, with a conference call scheduled for July 30, 2025, to discuss the results and recent developments [1][3] Financial Performance - Total steel shipments for the quarter are expected to be approximately 472,000 tons [2] - Adjusted EBITDA is anticipated to be in the range of ($30) million to ($35) million [2] Company Strategy and Operations - The CEO highlighted that the results were in line with expectations, particularly noting strength in the plate business despite macroeconomic uncertainties and tariff policies affecting the sector [3] - Algoma is advancing its transformation into one of North America's greenest steel producers, having achieved first arc and first steel production from its electric arc furnace project [3][8] Company Overview - Algoma is a fully integrated producer of hot and cold rolled steel products, including sheet and plate, and is a key supplier in North America [7] - The company is modernizing its plate mill and adopting electric arc technology to significantly lower carbon emissions, emphasizing its commitment to environmental stewardship [8]
The Simply Good Foods Company Reports Fiscal Third Quarter 2025 Financial Results and Updates Fiscal Year Outlook
Globenewswire· 2025-07-10 11:00
Core Insights - Simply Good Foods Company reported a 14% increase in net sales for the third quarter of fiscal year 2025, with organic net sales growth of approximately 4% [2][3] - The acquisition of Only What You Need, Inc. (OWYN) contributed significantly to the sales growth, with OWYN net sales accounting for 10% of the total reported net sales growth [3][8] - The company expects to generate approximately 3% organic net sales growth and mid-single-digit Adjusted EBITDA growth for the full fiscal year 2025 [2][17] Financial Performance - Net sales for the third quarter reached $381.0 million, an increase of $46.2 million or 13.8% compared to the previous year [3][14] - Gross profit increased to $138.5 million, reflecting a 3.7% rise year-over-year, although gross margin decreased by 350 basis points to 36.4% due to inflationary pressures [4][10] - Operating expenses rose to $79.2 million, with general and administrative expenses increasing significantly due to the inclusion of OWYN [5][11] Earnings Metrics - Net income for the third quarter was $41.1 million, a slight decrease of 0.6% from $41.3 million in the prior year [6][14] - Adjusted EBITDA for the quarter was $73.9 million, up 2.8% from $71.9 million year-over-year [6][13] - Adjusted diluted EPS was reported at $0.51, compared to $0.50 in the same period last year [7][45] Year-to-Date Performance - Year-to-date net sales reached $1,081.9 million, a 13.2% increase from the previous year, with OWYN contributing $99.6 million [8][14] - The company experienced a decline in international organic net sales, down $1.6 million compared to the prior year [8] Market Position and Strategy - Simply Good Foods is positioned as a leader in the nutritional snacking category, focusing on high-protein, low-sugar, and low-carb products [2][27] - The company aims to enhance growth through innovation, increased product availability, and effective marketing strategies [2][17] - The company anticipates continued challenges from inflation and tariffs but is implementing productivity and cost-saving measures to support long-term growth [2][17]
Theratechnologies Reports Financial Results for the Second Quarter 2025
Globenewswire· 2025-07-09 11:30
Core Insights - Theratechnologies Inc. reported strong demand for EGRIFTA SV with record high patient enrollments, achieving nearly $37 million in revenue for the first half of fiscal 2025 despite a supply shortage impact of $10-$12 million in Q1 [2][6][28] - The company is set to launch EGRIFTA WR, an improved version of EGRIFTA SV, in Q3 2025, leveraging the momentum from the past year [2][29] - The company has withdrawn its Fiscal 2025 revenue and Adjusted EBITDA guidance due to an announced acquisition by an affiliate of Future Pak [3] Financial Performance - For Q2 2025, consolidated revenue was $17.7 million, a decrease of 19.5% year-over-year, while the first half revenue was $36.8 million, down 3.9% from the previous year [6][24] - EGRIFTA SV net sales in Q2 2025 were $11.1 million, down 31.3% from $16.2 million in Q2 2024, while Trogarzo net sales increased by 13.4% to $6.6 million [5][10] - Adjusted EBITDA for Q2 2025 was $906,000, down from $5.5 million in Q2 2024, primarily due to increased spending and lower revenues from EGRIFTA SV [20][34] Cost Structure - Cost of goods sold for Q2 2025 was $4.7 million, representing 26.5% of revenue, compared to 20.7% in Q2 2024 [12][13] - R&D expenses decreased significantly to $2.6 million in Q2 2025 from $4.7 million in Q2 2024, attributed to reduced spending in oncology and F8 formulation programs [14][15] - Selling expenses increased to $6.8 million in Q2 2025, driven by higher compensation expenses related to market preparations [17][18] Net Loss and Financial Position - The company reported a net loss of $4.5 million for Q2 2025, compared to a net profit of $987,000 in Q2 2024, with a total net loss of $4.3 million for the first half of 2025 [24][27] - As of May 31, 2025, cash amounted to $9.5 million, with positive cash flows from operating activities of $2.7 million, indicating improved liquidity [26][27] Future Outlook - The company anticipates that existing cash and cash equivalents will be sufficient to fund operations for at least the next 12 months [26][30] - The successful transition from EGRIFTA SV to EGRIFTA WR is critical for meeting future revenue and EBITDA targets [29][30]
Shell second quarter 2025 update note
GlobeNewswire News Room· 2025-07-07 06:00
Core Insights - The company provides an updated outlook for Q2 2025, with expectations subject to finalization of results to be published on July 31, 2025 [1] Integrated Gas - Adjusted EBITDA production is expected to be between 900 - 940 kboe/d, down from 927 kboe/d in Q1 2025 [2] - LNG liquefaction volumes are projected to be between 6.4 - 6.8 million tonnes, slightly lower than 6.6 million tonnes in Q1 2025 [2] - Underlying operating expenses (opex) are expected to remain stable at 1.0 - 1.2 billion [2] - The taxation charge is anticipated to decrease to between 0.3 - 0.6 billion from 0.8 billion in Q1 2025 [2] Upstream - Production is forecasted to decline to between 1,660 - 1,760 kboe/d, down from 1,855 kboe/d in Q1 2025, due to scheduled maintenance and the sale of SPDC in Nigeria [4] - Underlying opex is expected to range from 1.9 - 2.5 billion [4] - The taxation charge is projected to decrease to between 1.6 - 2.4 billion from 2.6 billion in Q1 2025 [4] - Joint ventures and associates are expected to contribute approximately 0.2 billion in profit/loss, with exploration well write-offs estimated at 0.2 billion [4] Marketing - Sales volumes are expected to be between 2,600 - 3,000 kb/d, down from 2,674 kb/d in Q1 2025 [5] - Underlying opex is projected to be between 2.3 - 2.7 billion [5] - The taxation charge is expected to decrease to between 0.2 - 0.6 billion from 0.4 billion in Q1 2025 [5] - Adjusted earnings are anticipated to be higher than Q1 2025 [6] Chemicals and Products - The indicative refining margin is expected to increase to $8.9/bbl from $6.2/bbl in Q1 2025 [8][14] - The indicative chemicals margin is projected to rise to $166/tonne from $126/tonne in Q1 2025, although adjusted earnings are expected to be a loss [8][14] - Refinery utilization is expected to improve to between 92% - 96% from 85% in Q1 2025, while chemicals utilization is expected to decline to between 68% - 72% due to unplanned maintenance [8] Renewables and Energy Solutions - Adjusted earnings are expected to range from (0.4) - 0.2 billion, indicating a potential loss [9] Corporate - Adjusted earnings are projected to be between (0.6) - (0.4) billion, slightly worse than (0.5) billion in Q1 2025 [10] Shell Group - Cash flow from operations (CFFO) is expected to see tax payments between 2.8 - 3.6 billion, slightly lower than 2.9 billion in Q1 2025 [11] - Working capital movements are projected to range from (1) - 4 billion, compared to (2.7) billion in Q1 2025 [11] Guidance and Consensus - The company will publish consensus managed by Vara Research on July 23, 2025 [13]
Xeris Biopharma Holdings (XERS) 2025 Earnings Call Presentation
2025-07-03 13:51
Financial Outlook & Growth Strategy - Xeris expects total revenue of approximately $260 million to $275 million in 2025 and to maintain positive adjusted EBITDA [21] - The company anticipates total revenue to reach approximately $750 million by 2030, driven by Recorlev and the launch of XP-8121 [20, 127] - Xeris projects Recorlev to achieve peak net revenue between $1 billion and $3 billion, with XP-8121 also expected to reach $1 billion to $3 billion in peak net revenue [23, 99, 132] Recorlev Growth Opportunities - Recorlev is expected to approach $1 billion in annual net revenue [26, 40] - The U S addressable market for hypercortisolism is estimated at 3 to 5 million patients [23] - Recorlev inhibits cortisol production at multiple points in the cortisol production pathway [32] XP-8121 Hypothyroidism Treatment - XP-8121 is designed to improve patient experience and clinical outcomes in hypothyroidism [91] - XP-8121 targets a U S addressable market of 3 to 5 million treated patients with inconsistent TSH levels [23, 100] - XP-8121 has a multi-billion dollar peak revenue potential [98] Operational & Commercial Strengths - Xeris has a management team with experience in promoting pharmaceutical products and expertise in market preparedness [114] - The company has in-house capabilities across rare, ultra-rare, and retail markets, with dedicated sales, patient support, and medical education [114] - Xeris' commercial model is designed to drive continuous rapid growth [115]
Caesars Entertainment(CZR) - 2016 Q4 - Earnings Call Presentation
2025-07-03 07:59
Financial Performance - Continuing CEC的净收入为39亿美元,同比增长3%[17] - Continuing CEC的调整后EBITDA为11亿美元,同比增长9%[17] - Continuing CEC的调整后EBITDA利润率为27.6%,同比增长148个基点[17] - 企业范围内的净收入为84亿美元,同比增长1%[17] - 企业范围内的调整后EBITDA为22亿美元,同比增长6%[17] - 企业范围内的调整后EBITDA利润率为26.5%,同比增长117个基点[17] Key Initiatives and Investments - 移动网络增强功能使Caesars网站的收入和流量增加[22] - Total Rewards 数据库通过增加营销力度实现了增长[22] - Total Rewards 应用程序功能的增强带来了收入增长[22] - 企业范围内的拉斯维加斯现金ADR增长了17%[25] - 2016年,整个网络开设了23家新店[31] Operational Efficiency - 营销支出占净收入的百分比从2014年的27%下降到2016年的22%[36] - 每位全职员工的净收入从2014年的167000美元增加到2016年的204000美元[36] Employee Engagement and Customer Satisfaction - 员工敬业度:公司范围内的年度员工意见得分达到2005年以来的最高水平[17] - 客户满意度:总体客户服务得分达到历史最高水平[17]